Atlas Trials

Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)

Clinical trial NCT04085458 · COMPLETED

Trial details

NCT number
NCT04085458
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hemophilia A
Start date
2019-09-23
Primary completion
2022-05-20
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.